GB201206984D0 - New therapeutic use - Google Patents

New therapeutic use

Info

Publication number
GB201206984D0
GB201206984D0 GBGB1206984.5A GB201206984A GB201206984D0 GB 201206984 D0 GB201206984 D0 GB 201206984D0 GB 201206984 A GB201206984 A GB 201206984A GB 201206984 D0 GB201206984 D0 GB 201206984D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic use
new therapeutic
benzopyran
adamantyl
aminomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1206984.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manchester filed Critical University of Manchester
Priority to GBGB1206984.5A priority Critical patent/GB201206984D0/en
Publication of GB201206984D0 publication Critical patent/GB201206984D0/en
Priority to PCT/GB2013/050985 priority patent/WO2013156782A1/en
Priority to JP2015506307A priority patent/JP2015514742A/ja
Priority to EP13718049.3A priority patent/EP2844244A1/en
Priority to US14/395,409 priority patent/US20150133537A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1206984.5A 2012-04-20 2012-04-20 New therapeutic use Ceased GB201206984D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB1206984.5A GB201206984D0 (en) 2012-04-20 2012-04-20 New therapeutic use
PCT/GB2013/050985 WO2013156782A1 (en) 2012-04-20 2013-04-18 3- (1' -adamantyl) - 1 - aminomethyl - 3, 4 - dihydro - 5, 6 - dihydroxy - 1h - 2 - benzopyran for use in the treatment of a disease associated with beta-amyloid induced toxicity
JP2015506307A JP2015514742A (ja) 2012-04-20 2013-04-18 β−アミロイドにより誘発された毒性と関連する疾患の治療における、３−（１’−アダマンチル）−１−アミノメチル−３，４−ジヒドロ−５，６−ジヒドロキシ−１Ｈ−２−ベンゾピランの使用
EP13718049.3A EP2844244A1 (en) 2012-04-20 2013-04-18 3- (1' -adamantyl) - 1 - aminomethyl - 3, 4 - dihydro - 5, 6 - dihydroxy - 1h - 2 - benzopyran for use in the treatment of a disease associated with beta-amyloid induced toxicity
US14/395,409 US20150133537A1 (en) 2012-04-20 2013-04-18 3 - (1' - adamantyl) - 1 - aminomethyl - 3, 4 - dihydro - 5, 6 - dihydroxy - 1h - 2 - benzopyran for use in the treatment of a disease associated with beta-amyloid induced toxicity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1206984.5A GB201206984D0 (en) 2012-04-20 2012-04-20 New therapeutic use

Publications (1)

Publication Number Publication Date
GB201206984D0 true GB201206984D0 (en) 2012-06-06

Family

ID=46261631

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1206984.5A Ceased GB201206984D0 (en) 2012-04-20 2012-04-20 New therapeutic use

Country Status (5)

Country Link
US (1) US20150133537A1 (enExample)
EP (1) EP2844244A1 (enExample)
JP (1) JP2015514742A (enExample)
GB (1) GB201206984D0 (enExample)
WO (1) WO2013156782A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104644658A (zh) * 2013-11-22 2015-05-27 富力 人参皂苷Rg3在制备用于预防或/和治疗痴呆病症药物中的应用及药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT870757E (pt) * 1997-04-10 2002-09-30 Pfizer Derivados de adamantano substituidos por fluoro
WO2004103263A2 (en) * 2003-05-22 2004-12-02 Yeda Research And Development Co. Ltd. Dopamine and agonists and antagonists thereof for treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
US20150133537A1 (en) 2015-05-14
WO2013156782A1 (en) 2013-10-24
JP2015514742A (ja) 2015-05-21
EP2844244A1 (en) 2015-03-11

Similar Documents

Publication Publication Date Title
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
IN2015DN01156A (enExample)
UA115558C2 (uk) Алкілпіримідинові похідні для лікування вірусних інфекцій та подальших захворювань
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
EP2294184A4 (en) TREATMENT OF EYE DISEASES AND EXCESSIVE NEOVASCULARIZATION WITH THE HELP OF COMBINED THERAPY
MX2015007479A (es) Tiazolidindionas ahorradoras de receptores activados proliferadores de peroxisoma (ppar) y combinaciones para el tratamiento de enfermedades neurodegenerativas.
MX367618B (es) Compuestos de benzofuranilo y benzoxazolilo sustituídos, y sus usos.
EA201590930A1 (ru) Лекарственные формы руксолитиниба с замедленным высвобождением
GB201209613D0 (en) New compounds
MX346147B (es) Compuestos de 3-aril-5-substituido-isoquinolin-1-ona y su uso terapeutico.
MX2020004183A (es) Compuestos aromaticos multisustituidos como inhibidores de serina proteasa.
PH12013501600A1 (en) Novel heterocyclic derivatives
MX349004B (es) Nuevos compuestos.
MX2015005174A (es) Agente profilactico y/o terapeutico para sintomas conductuales y psicologicos asociados con la enfermedad neurodegenerativa o sintomas impulsivos asociados con enfermedad mental que contiene brexpiprazol o sales del mismo.
MY160241A (en) 5-alkynyl-pyrimidines
NZ712207A (en) Tetrahydropyrrolothiazine compounds
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
MX2015012435A (es) Derivados de 3-fenilpropilamina sustituidos para el tratamiento de enfermedades y trastornos oftalmicos.
MX2014012266A (es) Sintesis asimetricas para compuestos espiro-oxindol utiles como agentes terapeuticos.
PH12014502032A1 (en) Treatment of brain cancer
WO2013040227A3 (en) Therapeutic compounds
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
MX2014005209A (es) Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retencion de lagrimas.
WO2014035846A3 (en) Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)